Sign In
Buy LLY
$1,083.23
+18.39 (+1.73%)
At Close: Jun 03, 2026
Market Today: Lilly FDA Pill, McCormick-Unilever Deal, Oracle Cuts
05:35pm, Wednesday, 01'st Apr 2026
Guru Stock PicksPaul Singer has made the following transactions:Reduce in TFPM by 0.42%Stock News Lilly wins FDA nod for oral GLPâ1: Eli Lilly (LLY) secured F
Novo VP Weighs In on Approval of Lilly's Obesity Pill
05:14pm, Wednesday, 01'st Apr 2026
Jamey Millar, executive vice president, US Operations of Novo Nordisk, reacts to Eli Lilly's once-daily weight-loss pill, called Foundayo, winning FDA approval on "Bloomberg The Close." -------- More
Lilly to Acquire Centessa in $7.8 Billion Sleep Disorder Expansion
04:40pm, Wednesday, 01'st Apr 2026
Eli Lilly (LLY) is moving beyond its obesity franchise into another large and potentially underpenetrated category, agreeing to acquire Centessa Pharmaceuticals
Pricing and availability of Novo, Lilly's weight-loss drugs
03:07pm, Wednesday, 01'st Apr 2026
The U.S. Food and Drug Administration has approved Eli Lilly's oral weight-loss drug, orforglipron, branded as Foundayo, making it the second pill to enter the fast-growing obesity treatment market.
Lilly gains after FDA approves weight-loss pill, sizing down investor doubts
02:21pm, Wednesday, 01'st Apr 2026
Eli Lilly shares jumped nearly 6% on Wednesday after the U.S. Food and Drug Administration approved its weight-loss pill, Foundayo, marking a significant milestone in the drugmaker's efforts to exp
VIEW Lilly gets FDA nod for oral obesity pill, analysts see strong uptake potential
02:09pm, Wednesday, 01'st Apr 2026
The U.S. Food and Drug Administration has approved Eli Lilly's weight-loss pill, bringing another oral alternatives to a market dominated by injectables and intensifying competition with Novo Nordi
Eli Lilly opposes push to pass Trump's drug pricing deals into law, CEO says
01:32pm, Wednesday, 01'st Apr 2026
Eli Lilly opposes the White House's push to codify 'Most Favored Nations' drug pricing, Lilly CEO Dave Ricks said in an interview with CNBC. Lilly is one of more than a dozen pharmaceutical companies
Eli Lilly weight loss pill Foundayo approved by FDA, shares rise
01:24pm, Wednesday, 01'st Apr 2026
Eli Lilly and Co (NYSE:LLY) announced that the U.S. Food and Drug Administration (FDA) has approved Foundayo (orforglipron) for adults with obesity or those who are overweight with weight-related medi
Will Lilly (LLY) Beat Estimates Again in Its Next Earnings Report?
01:10pm, Wednesday, 01'st Apr 2026
Lilly (LLY) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Eli Lilly Jumps After Winning FDA Approval For Obesity Pill
12:02pm, Wednesday, 01'st Apr 2026
Eli Lilly stock jumped midday Wednesday after the Food and Drug Administration approved its weight-loss pill, now called Foundayo.
Eli Lilly Stock Jumps. A Weight-Loss Pill Is Officially on the Market.
11:50am, Wednesday, 01'st Apr 2026
Eli Lilly's Foundayo will be available to patients through the drugmaker's online pharmacy.
Lilly's weight-loss pill wins US approval
11:41am, Wednesday, 01'st Apr 2026
The U.S. Food and Drug Administration on Wednesday approved Eli Lilly's weight-loss pill, making it the second to market after Novo Nordisk's oral Wegovy, as the companies fight to �
The FDA approved Eli Lilly's new weight-loss pill, setting up a fight with rival Novo Nordisk over the next front in the booming market
11:38am, Wednesday, 01'st Apr 2026
The FDA go-ahead tees up a battle with rival Novo Nordisk over the next front in the booming weight-loss drug market.
Cramer's Mad Dash: Eli Lilly
11:31am, Wednesday, 01'st Apr 2026
CNBC's Jim Cramer delivers his daily Mad Dash.
Adults taking Foundayo lost an average of 27 pounds on the highest dose in the ATTAIN-1 clinical trial1 Foundayo, Lilly's second FDA-approved obesity medicine, will be available via LillyDirect ® wit
